David B. Roberts - 29 May 2025 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Role
President and Director, Director
Signature
/s/ Nathan Ulrich
Issuer symbol
LMAT
Transactions as of
29 May 2025
Net transactions value
$0
Form type
4
Filing time
02 Jun 2025, 16:17:14 UTC
Previous filing
31 Mar 2025
Next filing
10 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roberts David B President and Director, Director C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON /s/ Nathan Ulrich 02 Jun 2025 0001365731

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Dividend Equivalent Rights Award $0 +1 +5.5% $0.000000 16 29 May 2025 Common Stock 1 Direct F1
transaction LMAT Dividend Equivalent Rights Award $0 +2 +7.3% $0.000000 24 29 May 2025 Common Stock 2 Direct F2
transaction LMAT Dividend Equivalent Rights Award $0 +3 +12% $0.000000 32 29 May 2025 Common Stock 3 Direct F3
transaction LMAT Dividend Equivalent Rights Award $0 +3 +12% $0.000000 31 29 May 2025 Common Stock 3 Direct F4
transaction LMAT Dividend Equivalent Rights Award $0 +4 +24% $0.000000 22 29 May 2025 Common Stock 4 Direct F5
transaction LMAT Dividend Equivalent Rights Award $0 +5 +29% $0.000000 23 29 May 2025 Common Stock 5 Direct F6
transaction LMAT Dividend Equivalent Rights Award $0 +3 +104% $0.000000 6 29 May 2025 Common Stock 3 Direct F7
transaction LMAT Dividend Equivalent Rights Award $0 +0 +103% $0.000000 1 29 May 2025 Common Stock 0 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4 These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6 These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7 These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F8 These dividend equivalent rights accrued on a restricted stock unit award granted on 2/18/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.